Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Fda Approves First Digital Treatment For Depression is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
FDA clears first digital treatment for depression, but experts caution that research is still early
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ... Read More
BrainsWay Shares Jump Following FDA Approval of Accelerated Depression Therapy
BrainsWay Ltd. (NASDAQ:BWAY) saw its stock rise 6.3% on Tuesday after the U.S. Food and Drug Administration (FDA) approved an accelerated treatment protocol for the company’s Deep Transcranial ... Read More
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic Stimulation (TMS) system. The approval allows providers to treat patients ... Read More
BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment
The FDA clearance expands the acceptable protocols for BrainsWay's deep transcranial magnetic stimulation, a non-invasive treatment used to treat patients with major depressive disorder, including ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus